Title : Targeting Ornithine Decarboxylase by α-Difluoromethylornithine Inhibits Tumor Growth by Impairing Myeloid-Derived Suppressor Cells.

Pub. Date : 2016 Jan 15

PMID : 26663722






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Targeting Ornithine Decarboxylase by alpha-Difluoromethylornithine Inhibits Tumor Growth by Impairing Myeloid-Derived Suppressor Cells. Eflornithine ornithine decarboxylase, structural 1 Mus musculus
2 However, little is known about the effect of ornithine decarboxylase (ODC) inhibition by DFMO on antitumor immune responses. Eflornithine ornithine decarboxylase, structural 1 Mus musculus
3 However, little is known about the effect of ornithine decarboxylase (ODC) inhibition by DFMO on antitumor immune responses. Eflornithine ornithine decarboxylase, structural 1 Mus musculus
4 We showed in this study that pharmacologic blockade of ODC by DFMO inhibited tumor growth in intact immunocompetent mice, but abrogated in the immunodeficient Rag1(-/-) mice, suggesting that antitumor effect of DFMO is dependent on the induction of adaptive antitumor T cell immune responses. Eflornithine ornithine decarboxylase, structural 1 Mus musculus
5 We showed in this study that pharmacologic blockade of ODC by DFMO inhibited tumor growth in intact immunocompetent mice, but abrogated in the immunodeficient Rag1(-/-) mice, suggesting that antitumor effect of DFMO is dependent on the induction of adaptive antitumor T cell immune responses. Eflornithine ornithine decarboxylase, structural 1 Mus musculus
6 Our findings establish a new role of ODC inhibition by DFMO as a viable and effective immunological adjunct in effective cancer treatment, thereby adding to the growing list of chemoimmunotherapeutic applications of these agents. Eflornithine ornithine decarboxylase, structural 1 Mus musculus